Skip to content

Fnip1 Associated Syndrome Cn305587

Published: July 22, 2026Updated: August 20, 2026

A recently described genetic condition linked to FNIP1 gene mutations. It can affect multiple body systems. Treatment involves multidisciplinary care for specific symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe metabolic derangements (hypoglycemia, metabolic acidosis)

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Recurrent sinopulmonary infections

(respiratory)

Autoimmune lymphoproliferative syndrome-like features (lymphadenopathy, splenomegaly)

(immunologic)

Enteropathy with malabsorption

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Renal Function Surveillance

Regular assessment of kidney function including serum creatinine, urinalysis, and imaging to detect renal involvement associated with FNIP1-related kidney pathology.

monitoring
3

Renal-Protective Nutrition

Modified protein intake and electrolyte management tailored to preserve kidney function and manage metabolic abnormalities in FNIP1-associated syndrome.

dietary

Additional treatment options

Blood Pressure Optimization

Antihypertensive therapy to maintain renal-protective blood pressure targets and reduce cardiovascular complications associated with metabolic dysfunction.

medication

Renal Biopsy When Indicated

Histological evaluation of kidney tissue to characterize FNIP1-related nephropathy and guide personalized treatment decisions.

procedure

Metabolic Activity Management

Balanced physical activity program with attention to hydration status and avoidance of nephrotoxic exposures to support overall metabolic health.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Fnip1 Associated Syndrome Cn305587?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Fnip1 Associated Syndrome Cn305587. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy